Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Ezetimibe with Statins in HoFH
NCT03885921Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2000
- Primary completion
- Jul 2003
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of ezetimibe in homozygous familial hypercholesterolemia (HoFH) (2 arms), sponsored by Organon & Co. Primary endpoints: Number of Participants Who Experience an Adverse Event at 24 months and Number of Participants Who Discontinue Study Treatment Due to an Adverse Event at 24 months. Started Oct 2000; status: completed.
02
Drugs
ezetimibe
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT03885921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885921.